National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 276647

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

276647
VAERS Form:
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2007-02-09
Onset:2007-02-09
Submitted:2007-04-13
Entered:2007-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 - / -

Administered by: Other      Purchased by: Unknown
Symptoms: Erythema, Inappropriate schedule of drug administration, Injection site mass, Pruritus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMNICEF, ZYRTEC, cough, cold, and flu therapies, TOBRADEX
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type':

Write-up:Information has been received from a 21 year old female with no pertinent medical history and no history of drug reactions/allergies who on 09-FEB-2007 was vaccinated with first dose of Gardasil (yeast ) (lot # not reported) injection. Concomitant therapy"included cefdinir (OMNICEF), cetirizine hydrochloride (ZYRTEC), dexamethasone/tobramycin (TOBRADEX), cough, cold, and flu therapies (/"VIGRAMOX/") and antihistamine (unspecified). On 09-MAR-2007, the patient was vaccinated with second dose of Gardasil (ye


Changed on 12/8/2009

276647 Before After
VAERS Form:
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2007-02-09
Onset:2007-02-09
Submitted:2007-04-13
Entered:2007-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 - / -

Administered by: Other      Purchased by: Unknown Other
Symptoms: Erythema, Inappropriate schedule of drug administration, Injection site mass, Pruritus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMNICEF, ZYRTEC, cough, cold, and flu therapies, TOBRADEX
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': (blank) WAES0703USA01529

Write-up:Information has been received from a 21 year old female with no pertinent medical history and no history of drug reactions/allergies who on 09-FEB-2007 was vaccinated with first dose of Gardasil (yeast ) (lot # not reported) injection. Concomitant therapy"included therapy included cefdinir (OMNICEF), cetirizine hydrochloride (ZYRTEC), dexamethasone/tobramycin (TOBRADEX), cough, cold, and flu therapies (/"VIGRAMOX/") ("VIGRAMOX") and antihistamine (unspecified). On 09-MAR-2007, the patient was vaccinated with second dose of Gardasil (ye (yeast) (lot # not reported) injection. No concomitant therapy at the time of receiving the second dose of the vaccine. On approximately 09-FEB-2007, following the first injection, the patient experienced slight redness and itching which were gone by the next day (approximately 10-FEB-2007). Medical attention was sought. Also she had a "hard bump" at the injection site which lasted for approximately two weeks (approximately 23-FEB-2007) before going away. The hard bump felt like a knot in her skin. On 09-MAR-2007, the patient received second injection of Gardasil vaccine only one month after the first dose. At the time of reporting, she has not had any adverse experience following the second injection of vaccine. Additional information has been requested.


Changed on 6/14/2014

276647 Before After
VAERS Form:
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2007-02-09
Onset:2007-02-09
Submitted:2007-04-13
Entered:2007-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 - / -

Administered by: Other      Purchased by: Other
Symptoms: Erythema, Inappropriate schedule of drug administration, Injection site mass, Pruritus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMNICEF, ZYRTEC, cough, cold, and flu therapies, TOBRADEX
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES0703USA01529

Write-up:Information has been received from a 21 year old female with no pertinent medical history and no history of drug reactions/allergies who on 09-FEB-2007 was vaccinated with first dose of Gardasil (yeast ) (lot # not reported) injection. Concomitant therapy included cefdinir (OMNICEF), cetirizine hydrochloride (ZYRTEC), dexamethasone/tobramycin (TOBRADEX), cough, cold, and flu therapies ("VIGRAMOX") and antihistamine (unspecified). On 09-MAR-2007, the patient was vaccinated with second dose of Gardasil (yeast) (lot # not reported) injection. No concomitant therapy at the time of receiving the second dose of the vaccine. On approximately 09-FEB-2007, following the first injection, the patient experienced slight redness and itching which were gone by the next day (approximately 10-FEB-2007). Medical attention was sought. Also she had a "hard bump" at the injection site which lasted for approximately two weeks (approximately 23-FEB-2007) before going away. The hard bump felt like a knot in her skin. On 09-MAR-2007, the patient received second injection of Gardasil vaccine only one month after the first dose. At the time of reporting, she has not had any adverse experience following the second injection of vaccine. Additional information has been requested.


Changed on 5/14/2017

276647 Before After
VAERS Form:
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2007-02-09
Onset:2007-02-09
Submitted:2007-04-13
Entered:2007-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 - / -

Administered by: Other      Purchased by: Other
Symptoms: Erythema, Inappropriate schedule of drug administration, Injection site mass, Pruritus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMNICEF, ZYRTEC, cough, cold, and flu therapies, TOBRADEX
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES0703USA01529

Write-up:Information has been received from a 21 year old female with no pertinent medical history and no history of drug reactions/allergies who on 09-FEB-2007 was vaccinated with first dose of Gardasil (yeast ) (lot # not reported) injection. Concomitant therapy included cefdinir (OMNICEF), cetirizine hydrochloride (ZYRTEC), dexamethasone/tobramycin (TOBRADEX), cough, cold, and flu therapies ("VIGRAMOX") and antihistamine (unspecified). On 09-MAR-2007, the patient was vaccinated with second dose of Gardasil (yeast) (lot # not reported) injection. No concomitant therapy at the time of receiving the second dose of the vaccine. On approximately 09-FEB-2007, following the first injection, the patient experienced slight redness and itching which were gone by the next day (approximately 10-FEB-2007). Medical attention was sought. Also she had a "hard bump" at the injection site which lasted for approximately two weeks (approximately 23-FEB-2007) before going away. The hard bump felt like a knot in her skin. On 09-MAR-2007, the patient received second injection of Gardasil vaccine only one month after the first dose. At the time of reporting, she has not had any adverse experience following the second injection of vaccine. Additional information has been requested.


Changed on 9/14/2017

276647 Before After
VAERS Form:(blank) 1
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2007-02-09
Onset:2007-02-09
Submitted:2007-04-13
Entered:2007-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 1 - / -

Administered by: Other      Purchased by: Other
Symptoms: Erythema, Inappropriate schedule of drug administration, Injection site mass, Pruritus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMNICEF, ZYRTEC, cough, cold, and flu therapies, TOBRADEX
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES0703USA01529

Write-up:Information has been received from a 21 year old female with no pertinent medical history and no history of drug reactions/allergies who on 09-FEB-2007 was vaccinated with first dose of Gardasil (yeast ) (lot # not reported) injection. Concomitant therapy included cefdinir (OMNICEF), cetirizine hydrochloride (ZYRTEC), dexamethasone/tobramycin (TOBRADEX), cough, cold, and flu therapies ("VIGRAMOX") and antihistamine (unspecified). On 09-MAR-2007, the patient was vaccinated with second dose of Gardasil (yeast) (lot # not reported) injection. No concomitant therapy at the time of receiving the second dose of the vaccine. On approximately 09-FEB-2007, following the first injection, the patient experienced slight redness and itching which were gone by the next day (approximately 10-FEB-2007). Medical attention was sought. Also she had a "hard bump" at the injection site which lasted for approximately two weeks (approximately 23-FEB-2007) before going away. The hard bump felt like a knot in her skin. On 09-MAR-2007, the patient received second injection of Gardasil vaccine only one month after the first dose. At the time of reporting, she has not had any adverse experience following the second injection of vaccine. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=276647&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166